Catherine Brenner

Centre National de la Recherche Scientifique — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

66h-index28.6kcitations225works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mitochondrial Function and Pathology(74), Cell death mechanisms and regulation(57), ATP Synthase and ATPases Research(31), RNA Interference and Gene Delivery(30), Autophagy in Disease and Therapy(24)

Publications225 total

WITHDRAWN: 166P Plasma proteomic signature of sarcopenia in advanced cancer patients and its biological correlates
Annals of Oncology·2025
The pro-apoptotic peptide PEP-010 triggers apoptosis in pancreatic tumor models in monotherapy and in combination with gemcitabine independently of the KRAS status
Cancer Letters·2025
Apoptosis-inducing factor (AIF) at the crossroad of cell survival and cell death: implications for cancer and mitochondrial diseases
Cell Communication and Signaling·2025· 10 citedOpen Access
Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy
2025Open Access
C-terminal binding protein-2 triggers CYR61-induced metastatic dissemination of osteosarcoma in a non-hypoxic microenvironment
Journal of Experimental & Clinical Cancer Research·2025· 5 citedOpen Access
The Pro-Apoptotic Peptide Pep-010 Triggers Apoptosis in Pancreatic Tumor Models in Monotherapy and in Combination with Gemcitabine Independently of the Kras Status
SSRN Electronic Journal·2025Open Access
Metabolism: novel frontier for a multi-targeted approach in Neuroblastoma
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2024
Pharmacological evaluation of compounds inhibiting the mitochondrial protein complex AIF/CHCHD4
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2024
AIF-CHCHD4 dependent metabolic plasticity in pediatric cancer
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2024
The first-in-class pro-apoptotic peptide PEP-010 is effective in monotherapy and in combination with paclitaxel on resistant ovarian adenocarcinoma cell models
Frontiers in Pharmacology·2024· 6 citedOpen Access
A retrospective validation of the effective and safe treatment of patients on general care wards with high velocity nasal insufflation therapy utilizing prognostic risk scores during COVID-19
Journal of Mechanical Ventilation·2024Open Access
Abstract 2414: Feasibility and clinical utility of blood based NGS in head and neck carcinomas: A single center experience from precision medicine program
Cancer Research·2024
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Cell Death and Differentiation·2023· 326 citedOpen Access
Abstract 6129: The proapoptotic peptide PEP-010 is efficient on several models of different tumor origins and it can be monitored by pharmacodynamic biomarker candidates in clinical practice
Cancer Research·2023· 3 cited
Supplementary Table S1 from Chemosensitization by Knockdown of Adenine Nucleotide Translocase-2
2023Open Access
Supplementary Table 1, Figures 1 - 8 from Cisplatin Resistance Associated with PARP Hyperactivation
2023Open Access
Supplementary Figures S1 & S2 from Chemosensitization by Knockdown of Adenine Nucleotide Translocase-2
2023Open Access
Data from Cisplatin Resistance Associated with PARP Hyperactivation
2023Open Access
Data from Cisplatin Resistance Associated with PARP Hyperactivation
2023Open Access
Supplementary Table 1, Figures 1 - 8 from Cisplatin Resistance Associated with PARP Hyperactivation
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Guido Kroemer(34), Naoufal Zamzami(14), Helena L.A. Vieira(12), Isabel Marzo(10), Santos A. Susín(10), Lorenzo Galluzzi(9), Christophe Lemaire(8), Nathanaël Larochette(7), Ilio Vitale(6), Chahrazed El Hamel(6), David W. Andrews(5), Oliver Kepp(5), Morgane Le Bras(5), Stuart A. Aaronson(4), John Abrams(4), Emad S. Alnemri(4), Eric H. Baehrecke(4), Nicolás G. Bazán(4), Mikhail V. Blagosklonny(4), Klas Blomgren(4)